| Structure | Chemical Name | CAS | MF |
|
2-Pyrimidinamine,N,N-dimethyl-4-(1-methylethyl)-(9CI)
|
180283-89-0
|
C9H15N3
|
|
1-BENZYLPIPERAZINE-2-CARBOXYLIC ACID
|
180285-25-0
|
C12H16N2O2
|
|
METHYL 2-FLUORO-3-OXOPENTANOATE
|
180287-02-9
|
C6H9FO3
|
|
CALLITRIS INTROTROPICA WOOD OIL
|
180287-43-8
|
|
|
Trastuzumab
|
180288-69-1
|
C10H14N6O5
|
|
Ethanone, 1-(2-hydroxy-4-methyl-1,3-cyclohexadien-1-yl)- (9CI)
|
180292-79-9
|
C9H12O2
|
|
Ethanone, 1-(2-hydroxybicyclo[3.2.1]oct-2-en-3-yl)- (9CI)
|
180292-82-4
|
C10H14O2
|
|
Ethanone, 1-(3-hydroxybicyclo[2.2.2]oct-2-en-2-yl)- (9CI)
|
180292-83-5
|
C10H14O2
|
|
3(2H)-Thiophenone, dihydro-2-(1-hydroxyethylidene)-, (E)- (9CI)
|
180292-84-6
|
C6H8O2S
|
|
3(2H)-Thiophenone, dihydro-4-(1-hydroxyethylidene)-, (E)- (9CI)
|
180292-85-7
|
C6H8O2S
|
|
Cycloheptanol, 2,2-diethoxy-, (+)- (9CI)
|
180293-71-4
|
C11H22O3
|
|
Cyclooctanol, 2,2-diethoxy-, (+)- (9CI)
|
180293-73-6
|
C12H24O3
|
|
1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine
|
180300-43-0
|
C11H13N3O5
|
|
Carbamodithioic acid, diethyl-, 2,3,6,7-tetrahydro-2,6-dioxo-1,3,7-tri methyl-1H-purin-8-yl ester
|
180301-42-2
|
C13H19N5O2S2
|
|
Carbamodithioic acid, diethyl-, 2-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6 -dioxo-7H-purin-7-yl)ethyl ester
|
180301-43-3
|
C14H21N5O2S2
|
|
Carbamodithioic acid, diethyl-, 3-(2,3,6,7-tetrahydro-3,7-dimethyl-2,6 -dioxo-1H-purin-1-yl)propyl ester
|
180301-45-5
|
C15H23N5O2S2
|
|
3-CYANO-4-FLUOROBENZYL BROMIDE
|
180302-35-6
|
C8H5BrFN
|
|
1H-Pyrazol-5-amine, 4-chloro-3-ethyl-1-methyl-
|
180303-03-1
|
C6H10ClN3
|
|
Oxazole, 2-(4-ethoxyphenyl)-4,5-dihydro-4,4-dimethyl- (9CI)
|
180303-26-8
|
C13H17NO2
|
|
3,3-DIMETHYL-4'-FLUOROBUTYROPHENONE
|
180305-22-0
|
C12H15FO
|
|
(R)-ALPHA-PHENYL-1-PYRROLIDINEETHANAMINE
|
180305-85-5
|
C12H18N2
|
|
2-(1H-IMidazol-5-yl)ethanol hydrochloride
|
180307-01-1
|
C5H9ClN2O
|
|
Cyanamide, [1-(3-pyridinyl)ethylidene]- (9CI)
|
180307-10-2
|
C8H7N3
|
|
tert-Butyl 4-vinylpiperidine-1-carboxylate
|
180307-56-6
|
C12H21NO2
|
|
Ethanethioic acid, O-4-pyridinyl ester (9CI)
|
180308-29-6
|
C7H7NOS
|
|
2-Pyrimidinol, acetate (ester) (9CI)
|
180308-30-9
|
C6H6N2O2
|
|
Ethanone, 2,2,2-trifluoro-1-(2-methoxy-5-methylphenyl)- (9CI)
|
180311-39-1
|
C10H9F3O2
|
|
CATHEPSIN INHIBITOR II
|
180313-87-5
|
C27H27N3O6
|
|
3-(2-Propenylseleno)-L-alanine
|
180316-10-3
|
C6H11NO2Se
|
|
Proline, 4-hydroxy-5-oxo-, methyl ester, trans- (9CI)
|
180321-18-0
|
C6H9NO4
|
|
(1S,2S)-N-BOC-1-AMINO-2-PHENYLCYCLOPROPANECARBOXYLIC ACID
|
180322-79-6
|
C15H19NO4
|
|
(1R,2R)-N-BOC-1-AMINO-2-PHENYLCYCLOPROPANECARBOXYLIC ACID
|
180322-86-5
|
C15H19NO4
|
|
Cyclopentanecarboxylic acid, 3-(hydroxyimino)-, [R-(E)]- (9CI)
|
180323-33-5
|
C6H9NO3
|
|
Cis(1S,2R)-Methyl 3-aMinocyclopentanecarboxylate hydrochloride
|
180323-49-3
|
C7H14ClNO2
|
|
Cyclopentanecarboxylic acid, 3-(hydroxyimino)-, [S-(E)]- (9CI)
|
180323-54-0
|
C6H9NO3
|
|
Cyclopentanecarboxylic acid, 3-(hydroxyimino)-, [S-(Z)]- (9CI)
|
180323-55-1
|
C6H9NO3
|
|
Tricyclo[2.2.1.02,6]heptane-3-carboxylic acid, 5-oxo-, [1S-(1R*,2S*,3R*,4S*,6R*)]- (9CI)
|
180324-27-0
|
C8H8O3
|
|
|
ALUMINUM DICHLOROHYDREX PG
|
180324-83-8
|
|
|
Ethanone, 1-(3a,6a-dihydro-2-methyl-4H-cyclopenta[b]furan-3-yl)-, cis- (9CI)
|
180333-07-7
|
C10H12O2
|
|
1-Naphthaleneethanamine,2-ethoxy-(9CI)
|
180334-20-7
|
C14H17NO
|
|
TRIS(DIMETHYLAMINO)GALLANE DIMER
|
180335-73-3
|
C2H10GaN
|
|
2,6-ANHYDRO-3-DEOXY-D-LYXO-HEPT-2-ENONITRILE
|
180336-27-0
|
C7H9NO4
|
|
METHYL-2,6-ANHYDRO-3-DEOXY-D-LYXO-HEPT-2-ENONIMIDATE
|
180336-28-1
|
C8H13NO5
|
|
2,6-ANHYDRO-3-DEOXY-D-LYXO-HEPT-2-ENONAMIDINE HYDROCHLORIDE
|
180336-29-2
|
C7H12N2O4.ClH
|
|
4-(cyclohexylamino)benzonitrile
|
180336-49-6
|
C13H16N2
|
|
3-Benzofurancarboxylicacid,4,5,6,7-tetrahydro-4-(hydroxyimino)-,(E)-(9CI)
|
180339-29-1
|
C9H9NO4
|
|
3-Benzofurancarboxylicacid,4,5,6,7-tetrahydro-4-(hydroxyimino)-,(Z)-(9CI)
|
180339-31-5
|
C9H9NO4
|
|
4-[(Biphenyl-2-ylcarbonyl)amino]-2-chlorobenzoicacid
|
180340-01-6
|
C20H14ClNO3
|
|
5,6,7,8-TETRAHYDRO-4H-THIENO[3,2-B]AZEPINE
|
180340-57-2
|
C8H11NS
|
|
6-AMINO-5-BROMONICOTINIC ACID
|
180340-69-6
|
C6H5BrN2O2
|
|
METHYL 6-AMINO-5-BROMONICOTINATE
|
180340-70-9
|
C7H7BrN2O2
|
|
2H-1-Benzopyran,6-ethoxy-2,2-dimethyl-(9CI)
|
180341-24-6
|
C13H16O2
|
|
Benzoyl chloride, 2-ethyl-3-methoxy- (9CI)
|
180341-36-0
|
C10H11ClO2
|
|
2,1-Benzisoxazole-5-carbonitrile,3-methyl-(9CI)
|
180343-64-0
|
C9H6N2O
|
|
2H-Pyrrole,2-(bromomethyl)-5-ethoxy-3,4-dihydro-,(S)-(9CI)
|
180347-71-1
|
C7H12BrNO
|
|
N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-methyl-pyridine-2-sulfonamide
|
180384-56-9
|
C25H23N9O6S
|
|
TEZOSENTAN
|
180384-57-0
|
C27H27N9O6S
|
|
Tezosentan disodium
|
180384-58-1
|
C27H28N9NaO6S
|
|
BOC-3-CARBOXYMETHYL-1-PHENYL-1,3,8-TRIAZASPIRO[4 5]DECAN-4-ONE
|
180386-35-0
|
C20H27N3O5
|
|
Carbamic acid, (3,3-dimethoxypropyl)-, 1,1-dimethylethyl ester (9CI)
|
180387-11-5
|
C10H21NO4
|
|
Carbamic acid, (3,3-dimethoxypropyl)-, methyl ester (9CI)
|
180387-17-1
|
C7H15NO4
|
|
H-GLU-LYS-PRO-LEU-GLN-ASN-PHE-THR-LEU-CYS-PHE-ARG-NH2
|
180387-75-1
|
C68H107N19O17S
|
|
AMYLOID P COMPONENT (33-38) AMIDE
|
180387-76-2
|
C37H56N10O7S
|
|
8-O-4-DIFERULICACID
|
180387-79-5
|
C20H18O8
|
|
1-Cyclopropene-1-carboxylicacid,3,3-dimethyl-,ethylester(9CI)
|
180400-03-7
|
C8H12O2
|
|
1-Cyclopropene-1-carboxylicacid,2,3,3-trimethyl-,ethylester(9CI)
|
180400-04-8
|
C9H14O2
|
|
(Pyridin-4-ylmethyl)phosphonic Acid Monohydrate
|
180403-03-6
|
C6H10NO4P
|
|
2-piperidino-1,3-thiazole-5-carboxylic acid
|
180403-13-8
|
C9H12N2O2S
|
|
2-(2-PYRIDYL)ETHYLTHIOUREA
|
180403-26-3
|
C8H11N3S
|
|
3-(5-phenyl-4H-1,2,4-triazol-3-yl)-2H-chromen-2-one
|
180403-55-8
|
C17H11N3O2
|
|
CYFLUFENAMID
|
180409-60-3
|
C20H17F5N2O2
|
|
2,3-Difluoro-N-hydroxy-6-(trifluoroMethyl)benziMidaMide
|
180410-47-3
|
C8H5F5N2O
|
|
1,3-Dioxole,2,2,4-trifluoro-5-methoxy-(9CI)
|
180410-71-3
|
C4H3F3O3
|
|
6-FLUORO-3-(PIPERIDIN-4-YL)-1H-INDOLE HYDROCHLORIDE
|
180411-84-1
|
C13H16ClFN2
|
|
Cyclohexanepropanoic acid, 4-ethoxy-2-oxo-, trans- (9CI)
|
180413-78-9
|
C11H18O4
|
|
1H-Isoindol-4-amine, 2,3,3a,4,5,6-hexahydro-5-methyl-
|
180414-12-4
|
C9H16N2
|
|
1H-Pyrrole-1-carboxylicacid,3-ethenyl-2,5-dihydro-,methylester(9CI)
|
180414-22-6
|
C8H11NO2
|
|
N-Fmoc-O-Phenyl-L-Tyrosine
|
180414-93-1
|
C30H25NO5
|
|
FMOC-L-HOMOLEUCINE
|
180414-94-2
|
C22H25NO4
|
|
Pyrido[3,2-e]pyrrolo[1,2-a]pyrazine, 5,6-dihydro- (9CI)
|
180416-34-6
|
C10H9N3
|
|
2-(1-Piperazinyl)-benzoic acid ethyl ester
|
180417-98-5
|
C13H18N2O2
|
|
1-(b-D-2-Deoxyribofuranosyl)-4-methylindole
|
180420-84-2
|
C14H17NO3
|
|
5-Chloroquinoline-6-carbaldehyde
|
180421-64-1
|
C10H6ClNO
|
|
N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-3-[(Z)-[(5Z)-4-methyl-3,6-dioxo-5-(phenylmethylene)piperazinylidene]methyl]benzamidehydrochloride
|
180422-22-4
|
C39H39ClN4O5
|
|
1-(1-methyl-1-silacyclobutyl-1)-4-trimethylsilyloxybenzene
|
180424-48-0
|
|
|
SULFURIC ACID, ALUMINUM SALT (5:3), NONAHYDRATE
|
180424-96-8
|
3Al.4O4S.HO4S.9H2O
|
|
2-Furancarboxaldehyde, 5-(dimethylsilyl)- (9CI)
|
180460-95-1
|
C7H10O2Si
|
|
Hydrazinecarboxylic acid, (3-methylbutylidene)-, 1,1-dimethylethyl ester (9CI)
|
180462-76-4
|
C10H20N2O2
|
|
Hydrazinecarboxylic acid, 2-(3-methylbutyl)-, 1,1-dimethylethyl ester (9CI)
|
180462-81-1
|
C10H22N2O2
|
|
tert-butyl 2-[4-(trifluoromethyl)benzyl]hydrazinecarboxylate
|
180462-82-2
|
C13H17F3N2O2
|
|
Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-(hydroxymethyl)-, methyl ester (9CI)
|
180464-87-3
|
C8H12O3
|
|
Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-formyl-, methyl ester (9CI)
|
180464-92-0
|
C8H10O3
|
|
(S)-3-(Amino(carboxy)methyl)bicyclo[1.1.1]pentane-1-carboxylicacid
|
180465-02-5
|
C8H11NO4
|
|
SPIRO[INDENE-1,4'-PIPERIDIN]-3(2H)-ONE
|
180465-55-8
|
C13H15NO
|
|
1'-N-BOC-1,2-DIHYDRO-1'H-SPIRO[INDOLE-3,4'-PIPERIDINE]
|
180465-84-3
|
C17H24N2O2
|
|
Phosphorsure, [4-cyanophenyl)methyl]-, Dimethylester
|
180466-98-2
|
C10H12NO3P
|
|
(E)-N-(1-Iodoprop-1-en-3-yl)-3-beta-(4-fluorophenyl)-nortropane-2-beta-carboxylic acid methyl ester,
|
180468-34-2
|
C18H21FINO2
|
|
|
1(S)-Phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid 3(R)-quinuclidinyl ester monosuccinate ([R-(R*,R*)]-isomer, monoHCl salt)
|
180468-37-5
|
|
|
(1S,3S)-Solifenacin Hydrochloride
|
180468-38-6
|
C23H27ClN2O2
|
|
Solifenacin Hydrochloride
|
180468-39-7
|
C23H27ClN2O2
|